A second look at bivalirudin

This publication has 10 references indexed in Scilit:

• Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study
  American Heart Journal, 2001
• ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions
  Journal of the American College of Cardiology, 2001
• Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
  Chest, 2001
• ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)
  Published by Elsevier ,2000
• Clinical Outcomes of Bivalirudin for Ischemic Heart Disease
  Circulation, 1999
• Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty
  Circulation, 1997
• Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
  New England Journal of Medicine, 1995
• Hirulog in the Treatment of Unstable Angina
  Circulation, 1995
• Kinetic Mechanism for the Interaction of Hirulog with Thrombin
  Biochemistry, 1994
• Anticoagulant effects of hirulog, ∗∗Hirulog™ brand direct thrombin inhibitor. a novel thrombin inhibitor, in patients with coronary artery disease
  The American Journal of Cardiology, 1993